Intrauterine administration of autologous PBMC in patients with RIF.

Intrauterine administration of autologous peripheral blood mononuclear cells in patients with repeated implantation failure. - IUAPT

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTc050190121

Enrollment

200

Registered

2020-03-19

Start date

2017-02-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertile woman repeated implantation failure

Interventions

Intrauterine administration

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: the patients with repeated(over three times) implantation failure

Exclusion criteria

Exclusion criteria: Women whose age are under 17 or ovre 47 years old. Infertile women who cannot get high-grade blastcysts in In vitro fertilization (IVF) treatment cycles.

Design outcomes

Primary

Measure	Time frame
implantation rate,pregnancy outcome	—

Secondary

Measure	Time frame
the grade of embryos using this treatment, the flequency of treatment related complication	—

Countries

Japan

Contacts

Public ContactAsako Tamura

Kyoto university hospital

a_tamura@kuhp.kyoto-u.ac.jp+81-75-751-3269

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026